A61P 5/00
Drugs for disorders of the endocrine system
A61P5/00 (Drugs for disorders of the endocrine system) appears on 13,704 US grants and 20,289 published applications in this corpus.
Search patents in A61P- Granted patents
- 13,704
- Published applications
- 20,289
- Assignees
- 4,943
- Inventors
- 30,143
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 5 | 0 |
| 1978 | 11 | 0 |
| 1979 | 8 | 0 |
| 1980 | 14 | 0 |
| 1981 | 13 | 0 |
| 1982 | 10 | 0 |
| 1983 | 9 | 0 |
| 1984 | 19 | 0 |
| 1985 | 25 | 0 |
| 1986 | 25 | 0 |
| 1987 | 29 | 0 |
| 1988 | 16 | 0 |
| 1989 | 20 | 0 |
| 1990 | 22 | 0 |
| 1991 | 32 | 0 |
| 1992 | 29 | 0 |
| 1993 | 28 | 0 |
| 1994 | 36 | 0 |
| 1995 | 51 | 0 |
| 1996 | 84 | 0 |
| 1997 | 99 | 0 |
| 1998 | 163 | 0 |
| 1999 | 186 | 0 |
| 2000 | 212 | 0 |
| 2001 | 268 | 89 |
| 2002 | 315 | 473 |
| 2003 | 338 | 773 |
| 2004 | 290 | 990 |
| 2005 | 286 | 974 |
| 2006 | 391 | 918 |
| 2007 | 393 | 965 |
| 2008 | 441 | 1103 |
| 2009 | 518 | 1325 |
| 2010 | 724 | 1405 |
| 2011 | 723 | 1284 |
| 2012 | 830 | 1215 |
| 2013 | 997 | 964 |
| 2014 | 894 | 1134 |
| 2015 | 788 | 910 |
| 2016 | 664 | 919 |
| 2017 | 733 | 811 |
| 2018 | 555 | 708 |
| 2019 | 536 | 673 |
| 2020 | 493 | 584 |
| 2021 | 363 | 459 |
| 2022 | 284 | 416 |
| 2023 | 210 | 349 |
| 2024 | 224 | 345 |
| 2025 | 202 | 301 |
| 2026 | 90 | 202 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61P 5/14Drugs for disorders of the endocrine system: of the thyroid hormones3,258
- A61P 5/24Drugs for disorders of the endocrine system: of the sex hormones2,837
- A61P 5/48Drugs for disorders of the endocrine system: of the pancreatic hormones2,822
- A61P 5/38Drugs for disorders of the endocrine system: of the suprarenal hormones1,443
- A61P 5/06Drugs for disorders of the endocrine system: of the anterior pituitary hormones1,078
- A61P 5/18Drugs for disorders of the endocrine system: of the parathyroid hormones916
- A61P 5/10Drugs for disorders of the endocrine system: of the posterior pituitary hormones572
- A61P 5/02Drugs for disorders of the endocrine system: of the hypothalamic hormones569
Recent patents
- Methods and compositions for treating glucocorticoid excess15 Sep 2026US 12,734,155 B2Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess15 Sep 2026US 12,734,156 B2Sparrow Pharmaceuticals, Inc.
- Pyridazinone compounds25 Aug 2026US 12,715,858 B2Inventisbio Co., Ltd.
- Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same18 Aug 2026US 12,708,625 B2Dongguk University Industry-Academic Cooperation Foundation
- Methods and compositions for reducing parathyroid levels18 Aug 2026US 12,708,629 B2Eirgen Pharma Ltd.
- Compositions and methods for the treatment of congenital adrenal hyperplasia8 Oct 2026US 2026/0306485 A1Crinetics Pharmaceuticals, Inc.
- Polymer-based therapeutics for inductive browning of fat8 Oct 2026US 2026/0306643 A1Purdue Research Foundation
- Treatment of hypoparathyroidism using triphenyl calcilytic compounds1 Oct 2026US 2026/0294857 A1Calcilytix Therapeutics, Inc.
- Dosage regime of crinecerfont for treating congenital adrenal hyperplasia in a pediatric subject1 Oct 2026US 2026/0294876 A1Neurocrine Biosciences, Inc.
- Treatment of thyroid eye disease with satralizumab1 Oct 2026US 2026/0297203 A1Chugai Seiyaku Kabushiki Kaisha
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Modified antibody variable domains462US 5,766,886 AXoma Corporation · 1998